Warsaw-based Zimmer Biomet Holdings Inc. (Nasdaq: ZBH) has received FDA clearance for the ROSA Knee System for robot-assisted knee replacement surgeries. The ROSA system includes 3D pre-operative tools and uses real-time data on anatomy to improve bone-cutting and restoration of natural joint movement.
"Complementing the skill and expertise of the surgeon with ROSA Knee’s robotically-assisted technologies can improve accuracy, precision and consistency, which can improve patient satisfaction, clinical outcomes and efficiency," said Christopher J. Cannova, M.D., Washington Joint Institute at OrthoBethesda. "ROSA Knee functions as a surgical assistant that gives me the tools and real-time data to perform bone cuts with greater precision and improve patient-specific soft-tissue balancing and implant alignment, without losing my feel for a natural fit and flexion."
The company’s ROSA Robotics platform also includes ROSA Brain for certain neurological procedures. The company also received FDA clearance for its Persona revision knee implant in late 2018.